Agenda

Dr. Prystowsky is a graduate of Pennsylvania State University and the Mt. Sinai School of Medicine. He completed his internal medicine training at Mt. Sinai Hospital, New York City, and training in cardiology and clinical electrophysiology at Duke University Medical Center, Durham, North Carolina.
From 1979 to 1986, Dr. Prystowsky was Director of the Electrophysiology Laboratory at the Indiana University School of Medicine. In 1986, he was Professor of Medicine and Director of the Cardiac Arrhythmia Center at Duke. He joined St. Vincent in 1988 and is Director of the Cardiac Arrhythmia Service. He is also Consulting Professor of Medicine at Duke University Medical Center.
He has authored, Cardiac Arrhythmias: An Integrated Approach for the Clinician; and Clinical Electrophysiology Review, and over 780 publications concerning cardiac arrhythmias. He was the Editor-in-Chief of The Journal of Cardiovascular Electrophysiology for 15 years.
Additionally, he is past chairman of the American Heart Association’s Committee on Electrocardiography and Electrophysiology, past president of the Heart Rhythm Society, and past chairman of the Test Writing Committee for Clinical Electrophysiology for the American Board of Internal Medicine. He is the recipient of the Distinguished Alumni Award from Pennsylvania State University (2007), the Distinguished Physician Award from St. Vincent Hospital (2014), the HRS Distinguished Teacher Award (2002), President’s Award (2009), and Pioneer in Cardiac Pacing and Electrophysiology Award (2018).
Dr Prystowsky has been married to his wife Bonnie for 56 years, and has two sons, David and Daniel, and four grandchildren, Dylan, Laila, Amber and Noah.

Dr. scheinman is Professor of medicine at uCSF,former President of the Heart Rhythm Society and chief of the Genetic arrhythmia section at UCSF

Roderick Tung, MD, is a specialist in cardiac electrophysiology. He is an expert in the management of heart rhythm disorders (arrhythmias), with a particular focus on advanced therapies for atrial fibrillation and ventricular arrhythmias. He specializes in catheter ablation — a procedure that targets and cauterizes abnormal tissue to eliminate heart rhythm irregularities. Dr. Tung is also one of a few electrophysiologists in the world who routinely performs epicardial mapping and ablation.

In addition to Dr. Tung's clinical work, he is dedicated to researching and investigating new and innovative ways to treat and manage arrhythmias. He currently serves as the principal investigator for several prospective clinical trials focusing on the role of robotic navigation, high-density multi-electrode mapping and early intervention to improve patient survival. Dr. Tung's work has been published in numerous respected, peer-reviewed journals, including Circulation, Journal of the American College of Cardiology, Heart Rhythm, Circulation: Arrhythmia Electrophysiology and Journal of Cardiovascular Electrophysiology.

Dr. Frank Cuoco is currently working as the co-director of Cardiac Electrophysiology and the Director of Cardiovascular Outreach for HCA Trident Health in Charleston, South Carolina. Prior to this, he served as Associate Professor in the Division of Cardiology and specializes in Cardiac Electrophysiology (EP) at the Medical University of South Carolina in Charleston, SC. During his tenure at MUSC, he served as both the Director of the Electrophysiology Lab and Operations and the Section Chief of Clinical Cardiac Electrophysiology.

Dr. Cuoco enjoys applying the basic science principles and problem solving skills he developed in his BME studies to the complex physiology associated with the diagnosis and treatment of abnormal heart rhythms (a.k.a. arrhythmias). Dr. Cuoco’s clinical practice focuses on the treatment of arrhythmias, which includes catheter ablation of arrhythmias, structural heart procedures (including left atrial appendage closure), and implantation of pacemakers, implantable cardioverter-defibrillators (ICDs), and other heart failure devices.

Dr. Cuoco’s research focuses on novel techniques and technology for catheter ablation procedures, as well as left atrial appendage closure devices and other cardiac diagnosis procedures. He has been amongst the top enrollers and proceduralists internationally for multiple clinical trials, including those for pulsed field ablation technology. He serves as a consultant and advisory board member for multiple biomedical technology companies focused on treatment of heart rhythm disorders.

Over the last 31 years I have been at Tufts Medical Center for 23 and UTSouthwestern Medical Center for 8. My clinical and research interests intersect. I am a clinician-scientist whose patients and research interest are primarily arrhythmias and sudden cardiac death in various heart conditions.

Atrial fibrillation is the major arrhythmia that electrophysiologists treat and its prevalence is increasing in the US and indeed in the world. As such, it is a major part of my clinical and research activity. Clinically, atrial fibrillation ablations are one of my most common procedures. I particularly enjoy redo ablations although I hope they are redo’s from someone else and not from my prior ablation.

Academically, I have been involved with several studies of atrial fibrillation, speak frequently about atrial fibrillation and have published several articles on atrial fibrillation. Atrial fibrillation in patients with hypertrophic cardiomyopathy is a particular interest of mine.

In my role as Associate Editor at Circulation I am responsible for handling the bulk of manuscripts on atrial fibrillation. This includes initial review and decision of whether to send out for review, reviewing after external review, and presenting them in our weekly meeting.

My other major focuses have been hypertrophic cardiomyopathy, sudden cardiac death (SCD), and in particular commotio cordis.

I have been on multiple AHA/ACC/HRS Writing Groups. I was on the AHA/ACC writing group on Atrial Fibrillation. I am currently on the Writing Group for ACLS with a publishing date in 2025.

Ravi Ranjan, M.D., Ph.D., is tenure Professor of Medicine and Section Chief of Cardiac Electrophysiology at the University of Utah. He has built a large clinical cardiology and electrophysiology practice in Utah and leads a robust, extramurally funded research program (https://cvrti.utah.edu/the-ranjan-laboratory/). His research focuses on tissue- and organ-scale physiology and pathophysiology in conditions such as atrial fibrillation, atypical left atrial flutter, ventricular tachycardia, and cardiac stereotactic radiotherapy. His group integrates cardiac computational modeling, machine learning, preclinical experimental models, cardiac magnetic resonance imaging, biochemical assays, electrophysiological mapping techniques, and human clinical data to study disease progression, develop treatment strategies, and advance understanding of cardiac physiology.

Dr. Russo is currently Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of the Division of Cardiology, Director of Electrophysiology and Arrhythmia Services, and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Health Care in Camden, New Jersey. She was Past President of the Heart Rhythm Society. She has authored multiple manuscripts on a variety of arrhythmia and device topics and has been co-chair or member of various writing groups, including guideline, consensus, and appropriate use documents. In addition, she is a current Associate Editor for Circulation and Associate Editor for Circulation: Arrhythmia and Electrophysiology and serves on the editorial board for several peer reviewed journals. She has also served on steering committees, events committees, and data safety monitoring committees for several clinical trials. Areas of special interest include sex differences in arrhythmias, implantable cardioverter defibrillators, atrial fibrillation therapy, and the role of digital health in arrhythmia management.

Luis Saenz, MD.
Cardiologist and Electrophysiologist.
Director of the International Arrhythmia Center at CardioInfantil Foundation, Bogota, Colombia.
Past President of the Latin-American Hearth Rhythm Society.
Member of the Editorial Board of the Journal of Interventional Cardiac Electrophysiology and Global Section Editor of the Journal of the American College of Cardiology EP.
Cofounder of the International Consortium EPLIVE.
Dr. Saenz is an international recognized leader with more than 20 years of experience in the field. Coauthor of several research papers and guidelines, Dr. Saenz is frequent invited speaker to lecture about catheter ablation of atrial fibrillation and ventricular arrhythmias that are his main topics of interest and expertise.

Dr. John Day graduated from medical school at Johns Hopkins University. He did his residency in internal medicine, cardiology, and cardiac electrophysiology fellowship training at Stanford University.

Dr. Day currently serves as head of cardiovascular services for the Mountain Star HCA Healthcare System. He has an extensive clinical practice focusing on atrial fibrillation at St. Mark’s Hospital in Salt Lake City, Utah.

Dr. Day previously served as president of the Heart Rhythm Society and is the immediate past president of the Utah chapter of the American College of Cardiology. He also previously served as the physician leader of Heart Rhythm Services for Intermountain Healthcare. He is recognized as an international thought leader, regularly speaking at medical conferences worldwide on the latest developments in treating atrial fibrillation.

Dr. Day is board certified in cardiology and cardiac electrophysiology. He has published more than 100 manuscripts, abstracts, and book chapters. Dr. Day is the former editor-in-chief of the Journal of Innovations in Cardiac Rhythm Management.

In 2017 Dr. Day published The Longevity Plan: Seven Life-Transforming Lessons from Ancient China, with Harper Collins as publisher. The Longevity Plan was an Amazon number one bestseller and was named a "best book" of 2017 by the Huffington Post and won the Nautilus Book Award Gold Medal for the best book of 2017. Dr. Day’s second book, The Atrial Fibrillation Cure, was also an Amazon bestseller in 2021 and was published by BenBella Books.

Dr. Liu is currently Associate Professor of Medicine at Weill Cornell Medical College and the Medical Director of Cardiac Electrophysiology Services for the New York-Presbyterian - Weill Cornell Network. He also leads the Complex Arrhythmia Ablation and Structural Heart Electrophysiology programs at Weill Cornell Medicine.
Dr. Liu was born in southern China and raised in New York City. After training in EP Fellowship at UPenn, Dr. Liu joined the faculty at Weill Cornell in 2008, where he has led successful programs in epicardial VT ablation, Lariat device closure of the left atrial appendage, cryo-balloon ablation for atrial fibrillation, Watchman and Amulet device closure of the left atrial appendage, physiologic conduction system pacing, and most recently pulsed-field ablation (PFA) for atrial fibrillation. Dr. Liu is a Fellow of the Heart Rhythm Society and the American College of Cardiology. He has dedicated increasing time to volunteer duties at the Heart Rhythm Society, with 3 years on the Reimbursement and Regulatory Affairs Subcommittee (including 1 year as Chair), followed by 3 years as Chair of Health Policy and Regulatory Affairs - where he led interactions between the EP community and the FDA, CMS, and other regulatory agencies, advocating for optimal patient access to arrhythmia care by EP experts. Dr. Liu continues to serve as HRS Advisor to the CPT Panel since 2022, and is part of the HRS Safety Alert Rapid Response Team - crafting recommendations for medical device advisories. Dr. Liu has started a 3-year term on the HRS Board of Trustees.

Dr. Walid Saliba is a staff cardiologist in the Section of Cardiac Electrophysiology and Pacing in the Department of Cardiovascular Medicine at Cleveland Clinic. Dr. Saliba is also the Medical Director of the EP lab and Director of the Atrial Fibrillation Center. He is trained in all aspects of clinical cardiac electrophysiology and pacing, including catheter ablation, epicardial access, LAA occlusion, implantation of cardiac pacemakers and defibrillators and extraction of implanted pacemaker and ICD leads using laser technology.
A native of Lebanon, Dr. Saliba did his undergraduate work at the American University of Beirut, continued at the American University and earned his medical degree. He is fluent in English, French and Arabic. He moved to the United States where he completed an internship and residency program in internal medicine at Duke University, a fellowship in Cardiology from Baylor College. The Cleveland Clinic awarded him a fellowship in cardiac electrophysiology and he was appointed to Cleveland Clinic as a staff cardiac electrophysiologist in 1999.
Dr. Saliba’s research has focused on topics related to new treatments of atrial fibrillation, stroke prevention strategies and pericardial ablation. He has been a guest lecturer and authored or co-authored numerous articles in leading scientific journals.
Dr. Saliba is a member of the American College of Cardiology and fellow of the Heart Rhythm Society.

Dr. Stavrakis is a clinical electrophysiologist and physician scientist at the University of Oklahoma Health Campus, where he also serves as the Director of Electrophysiology. His research has focused on autonomic modulation for the treatment of cardiovascular diseases, in both animals and humans. He has been continuously funded since 2012, from various sources, including the American Heart Association and the NIH. He has published >150 manuscripts over the last 10 years, in prestigious Cardiology journals, including Circulation, Circulation Research and the Journal of the American College of Cardiology. The significance of his work is being increasingly recognized and he has been invited to present in national and international meetings on this topic. He has mentored numerous fellows and junior faculty over the last 15 years.

Kamala P. Tamirisa, M.D., FACC, FHRS, FAHA, is an Associate Professor in the Division of Cardiology at UT Southwestern Medical Center and serves as Director of Electrophysiology Research. A cardiac electrophysiologist, Dr. Tamirisa specializes in atrial fibrillation, supraventricular tachycardia, advanced device therapy, conduction system pacing, cardiac resynchronization therapy, and arrhythmias in pregnancy. Her research focuses on arrhythmia management, access barriers to electrophysiology care, health care disparities, and workforce gaps in cardiovascular medicine. She is actively involved in national leadership as an HRS BOT member, as well as in advocacy, education, and mentorship within cardiology and electrophysiology.

Dr. Paul C. Zei is a cardiac electrophysiologist at Mass General Brigham - Brigham and Women’s Hospital in Boston, MA USA, where he is Director of the Atrial Fibrillation Program. He is also an Associate Professor of Medicine at Harvard Medical School, also in Boston. Dr. Zei is a graduate of Stanford University, after which he completed postgraduate training at Brigham and Women’s Hospital/Harvard Medical School.

His clinical interests are in atrial fibrillation and complex arrhythmia management. He is a founding leader of the BWH Atrial Fibrillation Center of Excellence. He performs complex ablation and device implantation, with a focus on atrial ablation. His research interests include advanced mapping technologies, new ablation technologies, machine learning in electrophysiology, fluoroscopy elimination techniques, intracardiac echocardiography, and non-invasive stereotactic cardiac radioablation.

USMAN R SIDDIQUI MD FHRS
CHIEF ELECTROPHYSIOLOGY
ADVENT HEALTH CELEBRATION
ASSOCIATE PROFESSOR OF MEDICINE
UNIVERSITY OF CENTRAL FLORIDA
Dr. Usman Siddiqui graduated from Dow Medical College in Karachi, Pakistan. He started his internal medicine training at the Cleveland Clinic Foundation in Cleveland, Ohio, prior to completing Cardiology fellowship training at the University of Miami. Dr. Siddiqui then went on to complete an additional fellowship in Electrophysiology at University of Miami’s Jackson Memorial Hospital. Since completing his training, Dr. Siddiqui has gone on to gain extensive experience in the field of electrophysiology. He serves as the lead electrophysiologist for Advent Health Florida’s EP division, as well as for the Central Florida Cardiac and Vascular Institute. Moreover, he is the Director of Electrophysiology at Advent Health Celebration and Nicholson center in Orlando, Florida. Dr. Siddiqui is also involved in academics, teaching, and consultation. As Associate Professor of Medicine at the University of Central Florida, Dr. Siddiqui plays an active role in educating medical students, residents, and fellows to shape the next generation of physicians. Additionally, he works as a consultant and in physician training and serves on the Advisory Board for several leading medical device companies and “startups”. He is actively involved in several IDE trials with the Advent Health Cardiovascular research foundation. Dr. Siddiqui is also the director of cardiovascular services at the Nicholson center and program director for several innovative educational programs and hands-on training to elevate operator skills and expertise.

Elaine M. Hylek, MD, MPH, is a Professor of Medicine at Boston University School of Medicine. She received her MD from the University of Pittsburgh School Of Medicine and a Masters in Public Health (quantitative methods) from Harvard University School of Public Health. She completed her residency training in internal medicine at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. Her research areas include arterial (stroke) and venous thrombosis, anticoagulant therapies, and atrial fibrillation. She has served as PI on several NIH R01 grants, served on the Executive Steering Committees for international clinical trials and national registries, Event Adjudication Committees, and Data Safety Monitoring Boards. She has also served as the Late Breaking Clinical Trial Discussant for multiple international trials in the field of thrombosis. Dr. Hylek is a former Section Editor for Thrombosis and Haemostasis, and a founding member of the International Society of Thrombosis and Haemostasis World Thrombosis Day initiative. Current roles include Director of the Thrombosis and Anticoagulation Service at Boston Medical Center. She is extensively published and designated a U.S. News Top Doctor and voted Best Doctors in America for the past decade.

BIOGRAPHICAL SKETCH

NAME
Wael A. Jaber, M.D.
POSITION / TITLE
Director of Cardiovascular Imaging Core Lab Staff and nuclear cardiology;
Professor of Medicine
Fuad Jubran Chair in Cardiovascular Medicine

EDUCATION / TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training)

INSTITUTION AND LOCATION
DEGREE (if applicable)
YEAR(S)
FIELD OF STUDY

American University of Beirut

American University of Beirut Dean’s Honors List

Residency

Fellowship

Fellowship
Bachelor of Science

Medical Degree

Internal Medicine

Cardiology

Cardiac Imaging
1985-1988

1988-1992

1992-1995

1995-1998

1998-1999
Biology

Medical School

St Luke’s Hospital (NYC)
St Luke’s Hospital (NYC)

Cleveland Clinic

Positions and Employment
2000 – Present Staff Cardiologist – Cleveland Clinic Foundation

Other Experience and Professional Membership

ACC: Fellow of American College of Cardiology
FESC: Fellow of European Society of Cardiology
FASNC: Member of Board of directors of American society of Nuclear Cardiology and a fellow of the society
FAES: Fellow of the American Society of echocardiography

Honors
Cleveland Clinic scientific innovator award, 2006
Cleveland Clinic Department of Cardiovascular Medicine Distinguished Teacher award 2005, 2014, 2021.
Cleveland Clinic International center Physician of the Year 2001.

SELECTED PEER-REVIEWED PUBLICATIONS (IN CHRONOLOGICAL ORDER).

‪Wael Jaber‬ - ‪Google Scholar‬

Dr. Marcos Daccarett, MD, MSc, completed his Cardiology and Cardiac Electrophysiology training at the University of Utah. As faculty with the University of Utah he received several research awards for his work in atrial fibrillation. With more than 20 years of clinical experience, he leads the Cardiac Electrophysiology program st St Luke's Boise, with emphasis in atrial fibrillation management including research in ablation technologies and left atrial appendage occlusion.

Luigi Di Biase, MD, PhD, FACC, FHRS, is System Director of Electrophysiology at Montefiroe Health System as well as Professor of Medicine (Cardiology) at the Albert Einstein College of Medicine.

Dr. Di Biase attended University of Bari in Bari, Italy, graduating from its medical school in 2000 and Cardiology residency program in 2004. In 2006, he completed a second-level master’s degree in Electrophysiology and Pacing at the University of Insubria, in Varese, Italy.

In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship at the Miller Family Heart & Vascular Institute at the Cleveland Clinic. Dr. Di Biase completed the PhD program in cardiovascular physiopathology at the University of Foggia, Italy, in 2010.

Dr. Di Biase's research focuses on cardiology and electrophysiology, with an emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. His research focuses on heart failure, particularly in cases treated with cardiac resynchronization therapy devices.
Dr. Di Biase is the author of more than 800 publications in indexed journals at high impact factor, about 800 abstracts, and 16 electrophysiology book chapters.
He has presented at numerous national and international conferences as an invited speaker.

Dr. Di Biase is a recipient of many international awards

Chad Lahman is a board-certified Family Nurse Practitioner. He joined the faculty of the Tulane University School of Medicine, Section of Cardiology as an Instructor of Medicine in January of 2024 and specializes in cardiac electrophysiology. Chad earned his Bachelor of Science in Nursing degree from Southeastern Louisiana University in 2015. He worked as a Registered Nurse at the Level 1 trauma center at Interim LSU Hospital (ILH) and University Medical Center of New Orleans (UMCNO) for four years, where he gained valuable experience in emergency medicine and critical care. After obtaining his Master of Science of Nursing degree from Southeastern Louisiana University in 2019, Chad spent five years refining his clinical skills and patient care expertise in the urgent care setting.

Christian Mahnkopf, MD, PhD, FESC, is a consultant cardiologist specializing in cardiovascular imaging, clinical and geriatric cardiology. Following his medical studies at Kiel University, he completed his residency and specialist training in Internal Medicine and Cardiology at Klinikum Coburg. In 2010, he undertook a postdoctoral research fellowship at the University of Utah, Salt Lake City, under the mentorship of Prof. Nassir Marrouche, focusing on atrial fibrillation and cardiac electrophysiology.

From 2021 to 2025, Dr. Mahnkopf served as Chairman of the Department of Cardiology at Klinikum Coburg. Since April 2025, he has been Senior Consultant in the Department of Internal Medicine at Martha-Maria Hospital St. Theresien, Nuremberg. He holds board certification in Internal Medicine and Cardiology and has additional certifications in Cardiac Magnetic Resonance Imaging (Level III, DGK/SCMR), Intensive Care Medicine, Emergency Medicine, Hypertension, and Heart Failure.

Dr. Mahnkopf's clinical and translational research is centered on advanced cardiovascular magnetic resonance imaging, with a particular focus on the characterization of atrial myopathy and its mechanistic role in atrial fibrillation, heart failure, and age-related cardiovascular disease. His work aims to improve phenotyping, risk stratification, and individualized therapeutic strategies through multimodality imaging.

He is a Fellow of the European Society of Cardiology (FESC) and an active member of the German Cardiac Society (DGK). He currently serves as the incoming Speaker of Working Group 29 (Geriatric Cardiology) of the DGK, promoting research and interdisciplinary collaboration in cardiovascular care for the ageing population.

Dr. Reddy is the Chief of Cardiac Electrophysiology and High and Bety Libby Endowed Professor at the University of Kansas Medical Center. He completed his residency and cardiovascular fellowships at Creighton University in Omaha Nebraska, Upon completion he did his fellowship in clinical cardiac electrophysiology at the University of Kansas Medical Center.

Dr. Reddy is the Chief of the Division of Cardiac Electrophysiology (Heart Rhythm Services) for the Department of Cardiovascular Medicine. He also the Program Director for the Cardiac Arrhythmia fellowship program.

In addition to being very busy clinically, Dr. Reddy is very passionate about teaching and clinical research. His research interests include left atrial appendage occlusion, artificial intelligence in medicine, complex arrhythmia management including ventricular tachycardia ablation and atrial fibrillation ablation. He has recently completed his MBA in Healthcare and plays many roles in hospital management.

He has had more than 150 articles published in peer reviewed medical journals to date and more than 350 abstracts presented at national and international meetings. He is invited as a faculty at multiple regional, national and international conferences.

Dr. Janet K. Han is a Clinical Professor of Medicine and cardiac electrophysiologist at UCLA and VA Greater Los Angeles Healthcare System where she is director of the Cardiac Arrhythmia Devices and Digital Health Program.
She has been a member of the Heart Rhythm Society since 2007 and is currently a member of the HRS Board of Trustees. She has been instrumental in the development of structured, real-time science communication for the HRS Annual Scientific Sessions. As Chair of the HRS Communications committee she helped to set the vision for HRS communications strategies, playing a critical role in the development of Heart Rhythm TV. As Chair of the Growth and Leadership Opportunities for Women in Electrophysiology she dedicated herself to the engagement and promotion of future leaders in EP.
She has worked with the National VA Office of Connected Care & the VA Innovations Ecosystem to cement the critical role of digital health and remote monitoring for Veterans’ arrhythmia care. She served as Vice Chair of the American College of Cardiology Digital Strategy Committee where she set policy governing ACC’s digital strategy. She was also co-chair for the 2024 American Heart Association Arrhythmia and EP Committee on Scientific Sessions Programming, Clinical Science co-lead, and continues to be a member of the AHA EP leadership committee.
Her research interests include implantable cardiac devices, arrhythmia management and prevention, and digital health including cardiac monitoring, wearables and remote monitoring, with scientific contributions including co-authoring international scientific statements, expert decision pathways & guidelines.

Dr. Kenneth Stein is the senior vice president and global chief medical officer, a
position he has held since February 2023.
In this role he has oversight for the clinical trials, medical safety and medical affairs
functions for Rhythm Management, the Global Clinical Operations (GCO) team and
Global Medical Affairs team and is responsible for ensuring a cohesive clinical
community of practice across the company. Dr. Stein also represents the clinical voice
for our investor audiences.
Prior to joining Boston Scientific, Dr. Stein held the position of Associate Director of
Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate
Professor of Medicine at Cornell University.
Dr. Stein is widely published, having authored over 150 peer-reviewed scientific
publications in the areas of cardiac electrophysiology with special interests in cardiac
resynchronization therapy and risk stratification for sudden cardiac arrest.
Dr. Stein is a Phi Beta Kappa graduate of Harvard College (in Economics) and an Alpha
Omega Alpha graduate from New York University School of Medicine. He completed
his medical internship and residency at The New York-Presbyterian Hospital/Weill
Cornell Medical Center, where he also completed his cardiology and cardiac
electrophysiology training.

Dr. Turakhia is an internationally recognized cardiac electrophysiologist, researcher, executive, and leader in digital health and heart rhythm care. He is Chief Medical Officer and Chief Scientific Officer at iRhythm Technologies, Inc, a publicly traded cardiovascular diagnostics and digital health company. He is Professor of Medicine at the Stanford University School of Medicine.

Trained in computer science, medicine, biostatistics, and research, he brings over 20 years of experience in patient care, outcomes research and trials, data science and artificial intelligence, medical device regulation, and the creation and commercialization of digital health products. At Stanford, he was the Co-Founder and Director of the Stanford Center for Digital Health. He has led several large-scale trials of digital health tools and wearables for heart disease, including as co-principal investigator of the landmark Apple Heart Study. For 14 years, he served as Chief of Cardiac Electrophysiology at the VA Palo Alto Health Care System, where he developed a best-in-class arrhythmia care program and where he continues to treat patients with arrhythmia procedures. In academic and industry roles, he has led teams to build and commercialize software-enabled remote patient monitoring platforms and electronic health record AI-guided knowledge extraction tools, most recently with 100Plus (acquired by Connect America) and Evidently (co-founder). Dr. Turakhia has authored over 300 publications and has received over $50 million in research funding as PI. Over the last 20 years, he has had several dozen leadership and clinical practice guideline author roles in HRS, AHA, ACC, EHRA, and ESC.

Dr. Nassir F. Marrouche is a globally renowned electrophysiologist and pioneer in the treatment of atrial fibrillation and its outcomes. He is a tenured Professor in the Division of Cardiovascular Medicine within the Department of Internal Medicine at Tulane University and is Director of the Cardiac Electrophysiology Division. He initiated a collaborative arrhythmia center that is bringing together a cross-departmental team of physicians, scientists, researchers, MRI and imaging specialists, and digital health experts dedicated to working collaboratively to improve successful prediction, prevention and outcomes in the treatment of cardiovascular disease using innovative approaches and technologies.

Dr. Marrouche is a Fellow of the American College of Cardiology and Heart Rhythm Society (HRS). He recently received the James H. Youngblood Excellence in Leadership Award as the Chair of the Digital Health Committee of HRS. In this position, Dr Marrouche has led multiple initiatives to improve the integration of digital technology into clinical practice. He has published his research findings in more than 200 peer-reviewed articles and prominent medical journals, including the New England Journal of Medicine, Circulation and Journal of the American Medical Association (JAMA).

Dr. Deering is a cardiac electrophysiologist at the Piedmont Heart Institute in Atlanta where he serves as Chief of the Arrhythmia Center, Chairman of the Clinical Centers for Excellence and Chief Quality Officer. He also serves as the chair of the Cardiac Governance Council for Piedmont Healthcare. He has participated in a variety of volunteer and leadership roles for the Heart Rhythm Society, functioning as president between May 2018 and May 2019. His research and clinical interests are focused on creating and implementing quality initiatives and programs in cardiac electrophysiology and cardiovascular medicine. Dr. Deering has served as a speaker and moderator at national and international electrophysiology and cardiology meetings; has authored and co-authored numerous publications addressing cardiac arrhythmia and cardiovascular quality issues; has coordinated and continues to participate in a number of cardiac electrophysiology arrhythmia research projects and serves as a reviewer and editorial board member for multiple cardiac electrophysiology and general cardiac journals. Dr. Deering earned his medical degree from Yale University School of Medicine. After finishing his post-graduate training at Yale he completed his cardiac electrophysiology fellowship at Tufts New England Medical Center. He has previously been a Clinical Assistant Professor of Medicine at Yale University School of Medicine and at present is a Clinical Associate Professor of Medicine at the Medical College of Georgia and the Mark E. Silverman, M.D. Educational Chair.

Dr. Sandeep K. Goyal, MD, FHRS, FACC is a board-certified cardiac electrophysiologist and Medical Director of the Electrophysiology Laboratories at Piedmont Heart Institute in Atlanta, Georgia. He specializes in advanced management of cardiac arrhythmias, with a focus on atrial fibrillation ablation, pulsed-field ablation technologies, intracardiac echocardiography–guided procedures, cardiac implantable devices, and left atrial appendage occlusion. Dr. Goyal is an active clinical investigator and national speaker, with a strong interest in innovation, workflow optimization, and the strategic growth of electrophysiology programs.

Dr. Michael J Riley earned his medical degree at Georgetown University. He completed Internal Medicine residency at Wasington University in St. Louis/Barnes-Jewish Hospital, Cardiovascular Disease fellowship at the Cleveland Clinic Foundation in Cleveland, OH, and EP fellowship training at Emory University. He is a Clinical Cardiac Electrophysiologist at Wellstar Cardiovascular Medicine in Marietta, GA.

Brett Gidney, MD, is a cardiac electrophysiologist specializing in the treatment of atrial fibrillation and other complex heart rhythm disorders. He is one of the highest-volume atrial fibrillation ablation operators in the United States and has personally performed more than 1,500 left atrial appendage closure procedures.

Dr. Gidney previously practiced at UCLA and is now with Pacific Central Coast Health Centers and CommonSpirit Health, where he provides electrophysiology services at Marian Regional Medical Center and French Hospital Medical Center on California’s Central Coast.

He has helped build nationally recognized atrial fibrillation and left atrial appendage closure programs, including centers designated for excellence in AF care and Watchman implantation. Dr. Gidney is particularly interested in improving procedural safety, expanding access to advanced rhythm care, and developing scalable systems for high-volume electrophysiology practice.

Will is a board certified Physician Assistant specializing in Cardiac Electrophysiology with over a decade of experience. He currently serves as the EP Advanced Practice team lead at the University of Utah and also functions as the Director of Advanced Practice in Cardiovascular Medicine.

His interests include management and treatment of cardiac arrhythmias, cardiac device troubleshooting and assisting in the EP Lab with procedures such as ablation, pacemaker/defibrillator implantation and lead extraction.

He is an IBHRE Certified Cardiac Device Specialist (CCDS) and Certified Electrophysiology Specialist (CEPS).

William completed his undergraduate studies at the University of Utah and went on to St. John’s University for his Physician Assistant training.

Dr. Eldadah is Physician Executive Director, Cardiac Electrophysiology, and Chief Strategy Officer, MedStar Heart and Vascular Institute. He completed a medical degree, a PhD in Human Genetics, and a residency in internal medicine at the Johns Hopkins University School of Medicine. He then stayed at Johns Hopkins to complete fellowships in clinical cardiology and cardiac electrophysiology before joining the faculty at MedStar Washington Hospital Center and MedStar Georgetown University Hospital in 2004.

He has been certified in internal medicine, cardiovascular disease, and cardiac electrophysiology by the American Board of Internal Medicine, and he is a Fellow of the American College of Cardiology and Heart Rhythm Society. Dr. Eldadah's clinical interests include all aspects of heart rhythm care with a special focus on atrial fibrillation and the use of medical devices to improve quality of life. His research interests include improving existing technology and developing novel ways of understanding and relieving heart rhythm problems, as well as better understanding genetic factors influencing atrial fibrillation and the risk of sudden cardiac death.

Rebekah Eutsler, MSN, FNP-C, is a board-certified Family Nurse Practitioner specializing in electrophysiology. She earned her Master of Science in Nursing with honors from Southeastern Louisiana University in December 2024 and her Bachelor of Science in Nursing from Louisiana College in 2008. Her practice focuses on atrial fibrillation, cardiac arrhythmias, and cardiac device management, with a commitment to comprehensive care for heart rhythm disorders.